Literature DB >> 1939548

Selective follicular reduction following ovulation induction by exogenous gonadotrophins in polycystic ovarian disease. A new approach to treatment.

H J Ingerslev1.   

Abstract

Seven patients with polycystic ovarian disease (PCO) and having polyfollicular development following ovulation induction by human menopausal gonadotrophin underwent selective follicular reduction by transvaginal ultrasound-guided aspiration of all follicles greater than or equal to 10 mm in diameter leaving two or three preovulatory mature follicles. Twenty-four and 48 h after injection of human chorionic gonadotrophin, the couples had intercourse. Five patients achieved pregnancy in 15 treatment cycles, four in their first cycle after 14 previous unsuccessful stimulation cycles. Four have delivered healthy children: three singletons and one set of twins. One patient spontaneously aborted twins in week 22 of pregnancy. No major complications were encountered. Selective follicular reduction seems to be a possible approach to the treatment of PCO patients having polyfollicular development following ovulation induction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939548     DOI: 10.1093/oxfordjournals.humrep.a137406

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Low multiple pregnancy rates and reduced frequency of cancellation after ovulation induction with gonadotropins, if eventual supernumerary follicles are aspirated to prevent polyovulation.

Authors:  C De Geyter; M De Geyter; E Nieschlag
Journal:  J Assist Reprod Genet       Date:  1998-03       Impact factor: 3.412

2.  Aspiration of excess follicles before intrauterine insemination in high response cycles.

Authors:  Begoña Prieto; Maria Diaz-Nuñez; Lucia Lainz; Alberto Vendrell; Aintzane Rabanal; Maria Iglesias; Teresa Jauregui; Beatriz Corcostegui; Ana Matorras; Silvia Perez; Roberto Matorras
Journal:  Reprod Med Biol       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.